While the needs of each client differ, the fundamentals of creative conception, strategic planning, professional execution and results that return the client’s investment define every project. This commitment is underscored not only by the number of companies which MCS has supported since 1985, but also by the long tenure of our relationships with many of these clients.
Adams Respiratory Therapeutics |
||
Auxilium Pharmaceuticals |
||
BD |
||
CSL Behring |
||
Genentech |
||
Qforma |
||
Regeneron Pharmaceuticals |
||
Schering-Plough |
||
Synergetics USA |
MCS provides disease-awareness communication to raise awareness of familial cold autoinflammatory syndrome and related conditions.
Regeneron is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of cancer, eye diseases, and inflammatory diseases and has preclinical programs in other diseases and disorders.
For more information on Regeneron, please visit the company's web site at www.regeneron.com.